Thursday, May 23, 2013 - 10:00am
2322 Rayburn
Background Documents and Information:
Witnesses:
Panel I
Janet Woodcock, M.D.
- Director
- Center for Drug Evaluation and Research
- Food and Drug Administration (FDA)
Panel II
Scott Gottlieb, M.D.
- Resident Fellow
- American Enterprise Institute
Joseph H. Harmison
- Owner, Harmison Pharmacies
- On behalf of National Community Pharmacist Association
Gerry Migliaccio
- Quality Systems Consultant
- Migliaccio Consulting
Elizabeth Scott (Scotti) Russell
- Government Affairs Manager
- National Association of Boards of Pharmacy
Gabrielle Cosel
- Manager, Drug Safety
- The Pew Charitable Trusts
Congress: